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ABSTRACT Parkinson’s disease is the second‐most‐common neurodegenerative disorder and can reduce patients’ quality
of life. The disease is caused by abnormalities in dopaminergic neurons, such as reactive oxygen species (ROS) imbalance
leading to programmed cell death, protein misfolding, and vesicle trafficking. Protein‐protein interaction (PPI) analysis has
been demonstrated to understand better candidate proteins that might contribute to multifactorial neurodegenerative
diseases, particularly in Parkinson’s disease. PPI analysis can be obtained from experiments and computational predictions.
However, experiment data is often limited in interactome coverage. Therefore, additional computational prediction methods
are required to provide more comprehensive PPI information. PPI can be represented as protein‐protein networks and
analyzed based on centrality measures. The previous study has shown that top‐k skyline query, a method using dominance
rule‐based centrality measures, reveals important protein candidates in Parkinson’s diseases. This study applied the top‐k
skyline query to PPIs containing experiment and prediction data to find important proteins in Parkinson’s disease. The result
shows that alpha‐synuclein (SNCA) is the most important protein and is expected to be a potential biomarker candidate for
Parkinson’s disease.
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1. Introduction
Parkinson’s disease (PD) is a disease that can be recog-
nized by several symptoms which may appear, such as
decreased motor functions, autonomic dysfunction, hal-
lucinations, and depression (DeMaagd and Philip 2015).
As the disease may worsen and cause pneumonia, it can
threaten the patients’ life. Furthermore, the disease can
lower patients’ quality of life and impact their families
and society (DeMaagd and Philip 2015). The disease bur-
den was estimated to rise from 4.1 to 4.6 million in 2005
to 8.3 to 9.3 million in 2030 (Dorsey et al. 2007), which
may broadly impact crowded nations, particularly several
Asian countries such as China, India, and Indonesia. Cur-
rently, PD has been known as one of the most common
neurodegenerative disorders with incidence ranging from
16 to 19 per 100,000 people per year (Twelves et al. 2003;
Lebouvier et al. 2009; WHO 2004) and expected to over-
come cancer as the second most common cause of death
in 2040. Furthermore, the economic burden of PD direct
and indirect cost of treatment reached US$ 1,100 million
worldwide (Twelves et al. 2003; WHO 2004).
PD is a disease known as neuron dysfunction. It
mainly impacts dopaminergic receptors due to several fac-
tors such as reactive oxygen species (ROS)-induced cell
death (Dias et al. 2013), protein misfolding (Tan et al.
2009), or changes of proteins that are responsible for vesi-
cle trafficking (Esposito et al. 2012), G protein activa-
tions (Odagaki and Toyoshima 2006), and many proteins
which should be noticed carefully. Proteins interact with
each other in carrying out their function and often called
protein-protein interaction (Chang et al. 2016). Protein-
protein interaction (PPI) is a good representation for un-
raveling protein functions, disease-disease, and disease-
gene associations (Liu et al. 2015; Chang et al. 2016).
Therefore, the PPI analysis to predict significant protein
candidates that play a role during the disease progression
provides a better understanding of multifactorial degener-
ative diseases, including PD.
Currently, many databases store PPI information, such
as STRING. STRING database (string-db.org) is a PPI
database with the largest number of organisms and pro-
teins (Szklarczyk et al. 2018). The database provides two
types of interaction. The first one is experimental data ob-
tained from experiments. The second type is prediction
interaction data obtained from many methods, including
co-expression analysis, detection of shared selective sig-
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nal across genomes, text-mining, and computational trans-
fer knowledge based on gene ontology (Szklarczyk et al.
2018). STRING’s experimental proteins interaction infor-
mation was collected from other databases such as BIND,
DIP, GRID, HPRD, IntAct, MINT, and PID.
PPI analysis is often limited by interactome coverage,
where interactome is a set of PPI that can occur inside a
cell (Yu and Fotouhi 2006). The interactome coverage is
a ratio between PPI that occurred inside the cell and inter-
actome often stated in percentage (%). For example, hu-
man is predicted to have 650,000 PPI (Stumpf et al. 2005).
However, Human Protein Reference Database (HPRD)
(https://hprd.org) , accessed in December 2019, only has
41,327 PPI information covering 6.3% interactome. Ex-
perimental data can be combined with prediction data To
improve interactome coverage (Jansen et al. 2002; Liu
et al. 2015).
The PPI network can be represented as a graph with
proteins as nodes and interactions as edges. The mea-
sure of centrality can be applied for finding the subnet-
work, even the importance of a node in a network. Thus,
data transformation can be done from a graph to an ob-
ject with centrality measures as attributes. However, there
were many centrality measures with different characteris-
tics, which led to debate among the researchers to deter-
mine which centrality measures are better (Raman et al.
2014).
In PPI analysis, clustering is frequently used to pre-
dict proteins function (Hao et al. 2016). Previously, sev-
eral studies focused on centrality measures and machine
learning were conducted to reveal PPIs subnetworks that
have an important role in certain diseases such as Diabetes
(Usman et al. 2019). In this study, we try to better under-
stand which proteins play a significant role in PD. Pre-
viously, Diansyah et al. performed the Skyline Query to
predict PPI in PD (Diansyah et al. 2019). In this study, we
performed Skyline Query, an algorithm for finding non-
dominated data, along with centrality measure to find sig-
nificant proteins of PD. Skyline query (SQ) is an algorithm
that shows the optimal solution for the problem with var-
ious criteria based on dominance rules (Borzsonyi et al.
2001). This algorithm is developed based on the maximal
vector problem in mathematics. The result of SQ is a set of
non-dominated objects called Skyline Objects. An object
dominates another object only if it has the same score or
a better score in all attributes and better at least in one at-
tribute (Borzsonyi et al. 2001). Commonly, SQ is used to
find the optimal object, for instance, a hotel or restaurant,
that meets multiple conflicting criteria.
In this study, we employed SQ to find the significant
proteins that have essential roles in the regulation of PD.
The logic of finding skyline object is in line with find-
ing significant proteins, which attribute values are not less
than that of any other protein and has at least one attribute
whose value is greater than that of any other protein. We
employed top-k SQ, one of the variants of SQ, to over-
come the weakness of SQ which is not robust against an
increasing number of attributes. We used seven centrality
measures, namely degree, betweenness, closeness, eigen-
vector, eccentricity, radiality, and bridging as attributes.
We combined experiment data and prediction data to im-
prove interactome coverage (Jansen et al. 2002).
2. Materials and Methods
We conducted this research in four stages. First, we col-
lected the necessary data for this research. Second, we per-
formed data pre-processing. This step included removing
duplicate data, deleting unconnected networks, and trans-
forming the network into centrality measures. Third, we
applied the Top-k Skyline Query to find the significant
proteins. Finally, we analyzed the results by conducting
a literature review to determine whether the Top-k Sky-
line Query could be used to find the significant proteins.
Figure 1 shows the flow chart of this research.
2.1. Dataset
We collected datasets fromOMIM (https://omim.org/) and
STRING database (https://string-db.org/) on March 11th,
2020. The OMIM database was used to find proteins asso-
ciated with PD.Moreover, the STRING database was used
to find the protein interaction associated with PD. The first
step was to find protein associated with PD from OMIM.
The query at OMIM was conducted using ”+” as a pre-
fix for every word. The prefix was used to get the precise
FIGURE 1 Flow chart of the study.
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result. The query for this study in OMIM is ”+Parkinson
+Disease”.
The second step is to find the PPI in STRING for pro-
teins that we get from OMIM. For each protein associated
with PD, there was a separate interaction file, so that we
needed to combine the data into one file. This study was
done by developing a program or scraper in Python 3.7
to automate this step. Figure 2 shows the pseudocode of
data scraping. Moreover, in this study, we used the com-
bination of the experimental dataset and prediction dataset
from STRING.
FIGURE 2 Pseudocode of data scraping.
2.2. Data pre‐process
Weused Cytoscape (https://cytoscape.org/) for conducting
pre-processing data. Two main steps in this study include
data cleaning and data transformation. First, we visual-
ized the PPI data to find any unconnected network. A Net-
work that was not connected to the main (biggest) network
would be removed. We assumed that the significant pro-
teins are located in the back bound network, a collection
of nodes with a high number of members and a high den-
sity. Thus, the unconnected networks to the back bound
were removed. Next, we omitted the duplicate interaction
data. The last step was to transform the data from the pro-
tein network into centrality measures. This process was
done by using CentiScaPe 2.2 in the Cytoscape applica-
tion (Scardoni et al. 2009; Scardoni and Lau 2012). After
data transformation was completed, proteins with seven
centrality measures were exported into a comma-separated
value file (csv). Next, the output was processed in further
steps.
2.3. Centrality Measures
Centrality measures are a unit of measure to measure the
important node in a network interaction and have been
widely used for analysis in biological networks. Many
centrality measures can be used to measure the importance
of a node. In this study, seven values of centrality mea-
sures were used, namely degree centrality, betweenness
centrality, closeness centrality, eigenvector centrality, ra-
diality, eccentricity, and bridging centrality.
Degree centrality is the simple calculation of central-
ity. Degree centrality is obtained by counting the number
of edges connected to the node. The probability of a pro-
tein becoming the center of regulation is directly propor-
tional to the greater degree of centrality (Scardoni and Lau
2012).
Betweenness centrality can be obtained by calculating
the shortest path by adding the shortest path through the
node divided by the total number of shortest paths in the
graph. The greater the betweenness centrality value, the
more likely the node is often bypassed for communication
between proteins so that the more relevant it is to become
a regulatory protein (Scardoni and Lau 2012).
The calculation for closeness centrality is based on the
number of shortest paths from one node to another node.
The value of the number of shortest paths is used as a divi-
sor of 1. Thus, the greater the value of closeness central-
ity, the more central the position of the protein is. There-
fore, it can become a regulatory protein for other proteins
in the network (Scardoni and Lau 2012) Eigenvector cen-
trality is calculated based on the concept that if a node-i
is connected to another node with a high score, node- i
will also have a high score (Scardoni et al. 2009). The
initial step in finding eigenvector centrality is to find the
largest eigenvalue first, then using the largest eigenvalue,
the eigenvector matrix will be obtained. The eigenvector
centrality value was obtained by dividing the eigenvector
matrix of a node by the determinant value of the eigenvec-
tor matrix. The greater the eigenvector centrality value in-
dicates if the node interacts with other important proteins
to become a regulatory center for other important proteins
(Scardoni et al. 2009).
Radiality is based on the shortest path from one node
to another node. Before adding up, the shortest path value
is used to reduce (∆G + 1) where ∆G is the largest shortest
path, after which it is added. The higher the radiality value
of a node is functionally relevant to other nodes. The high
values of radiality, eccentricity, and closeness centrality
indicate the consistency of a node to become the center of
the network (Scardoni and Lau 2012).
Eccentricity is calculated by finding the largest, the
shortest path from one node to another node. According
to Scardoni and Lau (2012), in biological terminology, ec-
centricity can indicate a protein’s convenience reached by
other proteins in the network. The greater the eccentricity
value suggests that it is easy to influence other proteins in
the network.
Bridging centrality is the result of the development of
betweenness centrality. The bridging centrality value is
obtained from the multiplication of the betweenness cen-
trality and the bridging coefficient. A node with a high
value of bridging centrality indicates if the node connects
a node with a high degree to connect between clusters in
the interaction network (Scardoni et al. 2009).
All values of centrality measures that have been de-
scribed will be used as attributes for each protein. Fur-
thermore, this data was used for the following process to
select interesting objects based on seven criteria of cen-
trality measures by using Skyline Query.
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2.4. Skyline Query
Skyline query (SQ) is a method to find the non-dominated
object; this algorithm chooses an interesting object from
a dataset. An object is later categorized as an interesting
object if not dominated by another object (Borzsonyi et al.
2001). For example, object A dominates object B if A has
the same score or a better score in all attributes than B and
better at least in one attribute (Borzsonyi et al. 2001). Then
this rule in SQ is called the dominance rule.
In this study, the higher score in centrality measures
means a higher chance of the protein being an important
protein for every centrality measure. So, the dominance
rule for Table 1 is the highest score in degree centrality and
closeness centrality. The results of implementation SQ in
Table 1 were the object A and C. Object B has the same
score as object A in terms of degree centrality. However, it
has a lower score in closeness centrality that makes object
A dominates object B. Object D is dominated byA because
it has the lowest score in every attribute compared to object
A. Since no other object can dominate object A and C,
object A and C became the skyline object for Table 1.






However, SQ has a weakness: the more attributes that
are used, the more skyline objects will be used so that the
results are no longer relevant (Kontaki et al. 2008). This
study used a developed SQ called top-k skyline query (top-
k SQ). Top-k SQ ranks skyline results to find the most im-
portant data in skyline objects. The ranking is done by
searching the most dominant data. This method finds data
that dominates other data, and the most dominant data was
in the top result. This study used centrality measures as at-
tributes and top-k SQ to analyze PPI.
Based on the concept of top-k SQ, a protein is a pro-
tein that is not dominated by another protein with the order
by how many proteins it dominated. The most important
result of top-k SQ is a candidate for important proteins re-
lated to the disease that was later further cross-checked.
Since there are many centrality measures, this study only
used basic centrality measures and the other two centrality
measures. The basic centrality measures in graph theory
are degree, betweenness, closeness, eigenvector, and ec-
centricity (Sharma et al. 2016). In this study, besides the
basic centrality measures, we used radiality and bridging
centrality.
We used top-k SQ to find an important protein of
PD using seven centrality measures (degree, betweenness,
closeness, eigenvector, eccentricity, radiality, and bridg-
ing). There are two interactions data types based on their
resources, experiment data and experiment+prediction
data. We used experimental data to determine whether
interactome coverage in PD good enough for PPI anal-
ysis. This study used SQ, an algorithm for finding non-
dominated data, and centrality measure to find important
proteins of PD.
2.5. Top‐k Skyline Query
Top-k representative skyline query (top-k RSP) is a top-k
SQ algorithm used to maximize data dominated by k sky-
line objects (Lin et al. 2007). The complexity for top-k
RSP is O(kn2+kn), where n is the total number of data.
This study chose a basic top-k SQ because the data is rel-
atively small, and the process is done only once. Figure 3
shows the pseudocode of top-k RSP.
FIGURE 3 Top‐k RSP pseudocode.
Using SQ, the skyline objects of data in Table 1 is ob-
ject A and object C. The object of D is dominated by object
A which has a better score in all dimensions than object D.
Object B is dominated by object A because it has a lower
score in closeness centrality. However, it has the same
degree centrality score. Object C dominates object B be-
cause it has the same score in closeness with a better score
in degree. Object A and object C is incomparable because
object A has a better score of closeness centrality; other-
wise, object C has a better degree of centrality. No other
data could dominate objects A and C, so objects A and C
are skyline objects.
FIGURE 4 Visualization for top‐k skyline query
Top-k SQ ranks the skyline objects by how much data
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were dominated by the skyline objects. As shown in Fig-
ure 4, object A dominates two data (D and B) while object
C only dominates one data (B). Object A is the highest
rank for top-k SQ because it dominates the most. There-
fore, the top-k SQ for Table 1 is A, and the top-k SQ for
Table 1 is A and C.
2.6. Data Analysis
The objective of this step is to analyze the result of top-k
SQ. The proteins relations to PD were cross-checked with
the experimental data, particularly the highest rank skyline
object we get from top-k SQ. Further analysis would de-
fine whether experiment and experiment + prediction data
can be used in the PD PPI analysis. We expect to see the
effect of interactome coverage.
3. Results and Discussion
There were 271 proteins data related to PD obtained from
OMIM, but only 252 proteins have interaction informa-
tion in STRING. Therefore, proteins associated with PD
which are not found in STRING were excluded from this
study. Two hundred and fifty-two protein interaction files
were merged into one for each interaction source. Table 2
shows the results from STRING after merging the interac-
tion files.
From Table 2, there are 1,553 proteins with 4,868 in-
teraction data with interaction source only from the exper-
iment. Meanwhile, there are 1,848 proteins with 8,577
interactions from experiment and prediction interaction
sources. Visualization of experimental data can be seen
in Figure 5. Figure 5 shows many unconnected networks.
Networks that are not connected to the main graph were
deleted. After the deletion of the unconnected graph, data
duplicate will be removed as well. Figure 5 shows the vi-
sualization for experiment data after data cleaning. In Fig-
ure 5 and Figure 6, the red nodes represent proteins asso-
ciated with PD that we obtained from OMIM. Meanwhile,
the green nodes represent protein without direct associa-
tion with PD (interaction protein from STRING).
TABLE 2 Results from STRING after merged.





However, deletion in duplicate data and unconnected
networks will decrease the number of proteins and inter-
actions. Table 3 shows the number of proteins and inter-
actions before the protein networks were transformed into
centrality measures. From Table 3, there are only 1,269
proteins and 4,198 interactions for the experiment data in-
teraction source. Moreover, 1,682 proteins with 7,894 in-
teractions left for the experiment+prediction data source.
TABLE 3 Results from STRING after data cleaning.
Interaction




After data cleaning, PPI networks were transformed
into centrality measures using CentiScaPe 2.2. There are
two default outputs: a name and a shared name. Since
FIGURE 5 Experiment data visualization before data cleaning.
FIGURE 6 Experiment data visualization after data cleaning.
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both contain the same protein name, the shared name
was omitted. The transformation data results are pro-
teins with seven centrality measures as attributes with one
protein name (name, degree centrality, betweenness cen-
trality, closeness centrality, eccentricity, eigenvector cen-
trality, bridging centrality, and radiality). The data is
transformed, then exported into a comma-separated value
(CSV) as the input for top-k SQ.
Data with interaction source experiment is processed
first. The maximum k for top-k SQ is 21 since there are
only 23 skyline objects resulting from SQ. Proteins in-
cluded in the top-21 SQ were SNCA (alpha-synuclein),
PARK2 (parkin RBR E3 ubiquitin-protein ligase), TRAF2
(TNF Receptor Associated Factor 2), FN1 (Fibronectin 1),
HSPA8 (Heat Shock Protein Family A (Hsp70) Member
8), GPR37 (G-Protein Coupled Receptor 37), TRAPPC1
(Trafficking Protein Particle Complex Subunit 1), LR-
RFIP1 (LRR binding FLII interacting protein 1), TH (Ty-
rosine Hydroxylase), GLB1 (Galactosidase beta 1), CTSA
(Cathepsin A), PTPRC (Protein Tyrosine Phosphatase
Receptor Type C), GSR (Glutathione-Disulfide Reduc-
tase), TNF (Tumor Necrosis Factor), C4BPA (Comple-
ment Component 4 Binding Protein Alpha), PRNP (prion
protein), TP53 (Tumor Protein 53), MAPK8 (Mitogen-
Activated Protein Kinase 8), SOD1 (superoxide dismu-
tase 1), HSP90AA1 (Heat Shock Protein 90 Alpha Family
Class A Member 1), and GNAI2 (G Protein Subunit Al-
pha I2). Table 4 shows the biological and experimental
associations of genes with PD.
However, the top-1 SQ is SNCA since SNCA domi-
natesmost data. The result for the top-3 SQ for experimen-
tal data can be seen in Table 5. SNCA is the most impor-
tant protein because it dominates another protein (1,217
proteins). Meanwhile, the other protein dominates only
vary from 0-14 proteins.
The following process used data interaction sources
were experiment and prediction. Maximum k for
top-k SQ for experiment+prediction data is ten since
there were only ten skyline objects. The results
were SNCA, TP53, KNG1 (Kininogen-1), PRDX5
(Peroxiredoxin-5), GTPBP4 (GTP Binding Protein 4),
PABPC1 (Polyadenylate-binding protein 1), ANXA1 (An-
nexinA1), AKT1 (RAC-alpha serine/threonine-protein ki-
nase), PARK2, and APP (Amyloid Beta Precursor Pro-
tein). Aside from SNCA, TP53, and PARK2, relations to
PD was shown in Table 6. In this table, we added further
information on other genes that were not mentioned in the
previous table.
Among ten skyline objects, the most important protein
is SNCA. SNCA results from a top-1 SQ; it means that
SNCA dominates another protein. Table 3 shows the re-
sult for top-3 SQ with experiment+prediction data as the
interaction source. Based on Table 5, SNCA dominates
1663 another protein, so that it becomes the most impor-
tant skyline object based on top-k SQ.
The execution time for the Python program is
0.2532 s for experimental data and 0.1508 s for experi-
ment+prediction interaction data. Since both data types
TABLE 4 List of proteins that related to Parkinson disease’s.
Proteins Association to Parkinson’s disease (PD)
GPR37 Highly expressed in neuronal progenitor cells, in par‐
ticular Wnt‐dependent neurogenesis (Berger et al.
2017)
GNAI2 Expression is increased during stress and plays im‐
portant role to inhibits adenylate cyclase, to mod‐
ulate cAMP mediated responsed beta adrenergic




Located in presynaptic terminals and critical to reg‐
ulate neurotramsiter release and vesicle trafficking
(Mata et al. 2010)
Commonly detected in Lewy bodies, which known
as pathologic features of PD (Siddiqui et al. 2016)
PARK2
Controls program cell death and apotptosis (Kono‐
valova et al. 2015)
PARK2 germlinemutations leading to cause neurons
dysnfunctions (Veeriah et al. 2010)
Mutations caused imbalance of program cell death





An enzyme in dopamine biosynthesis. TH expres‐
sion is foundly related to occurence of PD (Chen
et al. 2017)
HSPA8 Decreases during aging and may postulated to PD’s,
which may affect autophagy process due to re‐
sponse of ER stress by protein unfolding (Loeffler
et al. 2016)
TRAF2 Overexpression of TRAF2/6may induced by chronic
inflammations and hypothized to be reason of oc‐
curence PD (Chung et al. 2013)
TP53 One of the disease hallmark (Szybinska and Lesniak
2017)
SOD1
SOD1 proteinopathy known as neurotoxic superox‐
ide dismutase 1 (SOD1). SOD1‐associated familial
amyotrophic lateral






MAPK8 Downregulated and a possible biomarker of PD (Chi
et al. 2018)
C4BPA Not found
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TABLE 6 List of additional proteins that related to Parkinson’s dis‐
ease.
Proteins Association to Parkinson’s disease (PD)
KNG1 Level in cerebbrospinal is a potential marker of cog‐





AKT1 Involved in protection against PD (Xiromerisiou et al.
2008)
APP Not found
return the same protein that is SNCA as the important
protein, there is only one candidate for important pro-
tein. Among those proteins, at least five proteins were
found related to the PD. One of the most important pro-
teins was alpha-synuclein (SNCA). Biologically, SNCA
was responsible for presynaptic terminals and critical to
regulating neurotransmitter release and vesicle trafficking
(Mata et al. 2010). In addition, Alpha-synuclein is com-
monly detected in Lewy bodies, which is known as patho-
logic features of PD (Siddiqui et al. 2016).






Besides SNCA, several proteins are important in dis-
ease progressions; for instance, PARK2 controls pro-
grammed cell death and apoptosis (Chen et al. 2017).
PARK2 germline mutations are the leading cause of neu-
ron dysfunctions (Chi et al. 2018). PARK2 mutations
caused an imbalance of programmed cell death and in-
creased apoptosis (Konovalova et al. 2015). In GPCR
classes, the GRP37 gene is highly expressed in neuronal
progenitor cells, particularlyWnt-dependent neurogenesis
(Berger et al. 2017). GNAI expression increases during
stress and plays an important role in inhibiting adenylate
cyclase, modulating cAMP, and mediating responses to
beta-adrenergic stimuli (Tsolakidou et al. 2010). Lastly,
tyrosine hydroxylase (TH) is an enzyme in dopamine
biosynthesis, and since PD is related to dopaminergic neu-
rons, TH expression is also related to the occurrence of PD
(Chen et al. 2017).
SNCA is the first gene linked to PD. SNCA itself is
thought to have an essential role in synaptic transmission
(Mata et al. 2010). This protein has been given an iden-
tification name to show that SNCA is linked to PD and
plays an important role: PARK1 (Klein and Westenberger
2012). SNCA is considered involved in the early onset
of familial Parkinson’s disease (FPD) as a major causative
gene. It has been identified five mutations point in SNCA
that cause autosomal dominant Parkinson’s (Siddiqui et al.
2016). A study byDiansyah et al. (2019) found 14 proteins
resulting from a skyline query in PD, and SNCA is one
of the results. However, it still lacks information about
the most important protein to PD. This study shows that
SNCA is the most important protein for PD.
Experiment and experiment+prediction data give the
same result proving its significance. It shows that this
method can use experimental data in the PPI analysis for
PD. Also, it indicates that interactome coverage in PD is
good enough for PPI analysis since experiment data give
an important protein as the result of this method. However,
we need to do extended research to prove that interactome
coverage in PD is sufficient.
4. Conclusions
Based on the result of this study, it can be concluded
that the top-k skyline query can be used to find important
proteins in Parkinson’s disease (PD). Experiment and ex-
periment+prediction interaction data sources for PD can
be used in PPI Analysis using this method. The impor-
tant protein for PD based on this study is alpha-synuclein
(SNCA) that has been proven to have a significant role in
this disease.
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